Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Allison

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
The Lancet. Gastroenterology & Hepatology|January 18, 2021
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysisDavid Petroff, Valentin Blank, Philip N Newsome, et al.
Contemporary Clinical Trials|October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver diseaseTimothy Hardy, Kristy Wonders, Ramy Younes, et al.
Clinical Epigenetics|March 13, 2022
Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypesDenis Seyres, Alessandra Cabassi, John J Lambourne, et al.
Lancet (London, England)|December 4, 2019
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UKRoger Williams, Guruprasad Aithal, Graeme J Alexander, et al.
BMJ Open Gastroenterology|October 5, 2023
Quality standards for the management of alcohol-related liver disease: consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology ARLD special interest groupRichard Parker, Michael Allison, Seonaid Anderson, et al.
Journal of Hepatology|December 23, 2021
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver diseaseOlivier Govaere, Sine Kragh Petersen, Nuria Martinez-Lopez, et al.
Nature Genetics|May 18, 2026
Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitisMarkus Boesch, Seray Anak, Dania El Abyad, et al.
Hepatology (Baltimore, Md.)|February 15, 2024
Recent outcomes of liver transplantation for Budd-Chiari syndrome: A study of the European Liver Transplant Registry (ELTR) and affiliated centersEdo Dongelmans, Nicole Erler, Rene Adam, et al.
Contemporary Clinical Trials|October 6, 2023
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocolMichael Pavlides, Ferenc E Mózes, Salma Akhtar, et al.
Nature Metabolism|June 12, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
The Lancet. Gastroenterology & Hepatology|January 18, 2021
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysisDavid Petroff, Valentin Blank, Philip N Newsome, et al.
Contemporary Clinical Trials|October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver diseaseTimothy Hardy, Kristy Wonders, Ramy Younes, et al.
Clinical Epigenetics|March 13, 2022
Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypesDenis Seyres, Alessandra Cabassi, John J Lambourne, et al.
Lancet (London, England)|December 4, 2019
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UKRoger Williams, Guruprasad Aithal, Graeme J Alexander, et al.
BMJ Open Gastroenterology|October 5, 2023
Quality standards for the management of alcohol-related liver disease: consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology ARLD special interest groupRichard Parker, Michael Allison, Seonaid Anderson, et al.
Journal of Hepatology|December 23, 2021
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver diseaseOlivier Govaere, Sine Kragh Petersen, Nuria Martinez-Lopez, et al.
Nature Genetics|May 18, 2026
Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitisMarkus Boesch, Seray Anak, Dania El Abyad, et al.
Hepatology (Baltimore, Md.)|February 15, 2024
Recent outcomes of liver transplantation for Budd-Chiari syndrome: A study of the European Liver Transplant Registry (ELTR) and affiliated centersEdo Dongelmans, Nicole Erler, Rene Adam, et al.
Contemporary Clinical Trials|October 6, 2023
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocolMichael Pavlides, Ferenc E Mózes, Salma Akhtar, et al.
Nature Metabolism|June 12, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.
Pageof 10